Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme 4 selected

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 21 to 30 of 1577

TitleReference numberPublishedLast updated
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and overTA1147
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA1148
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitorsTA1146
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinomaTA1145
Transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistulaHTG777
Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (terminated appraisal)TA1144
Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopauseTA1143
Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophilsTA1142
Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shockHTG774
Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shockHTG775

Results per page

  1. 10
  2. 25
  3. 50
  4. All